MicroRNA as Markers in Testicular Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

MicroRNA as Markers in Testicular Cancer — Stella

Home/Testicular Germ Cell Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Testicular Germ Cell Cancer trials

Trial locations(6 sites)

Norway

Haukeland University Hospital, Bergen

Haugesund Hospital, Haugesund

Oslo University Hospital, Oslo

University Hospital of North Norway, Tromsø

Sweden

Sahlgrenska University Hospital, Gothenburg

Karolinska University Hospital, Stockholm

Key details

Sponsor

Haukeland University Hospital

Collaborators

Karolinska University Hospital, Sahlgrenska University Hospital

Enrollment target

~350 participants

Started

December 2016

Primary completion

December 2026

Age range

18 Years – 70 Years

Sex

Male only

Last updated August 2022

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.